Medicine & Life Sciences
Angiotensin-Converting Enzyme Inhibitors
100%
Heart Failure
75%
Cohort Studies
67%
Potassium
67%
Carboxylesterase
66%
Hyperkalemia
61%
Kidney
49%
Oculocerebrorenal Syndrome
41%
Spironolactone
40%
Genes
38%
Confidence Intervals
37%
Angiotensin II Type 1 Receptor Blockers
33%
Autosomal Dominant Polycystic Kidney
32%
Membranous Glomerulonephritis
31%
Calcineurin Inhibitors
30%
Nephritis
29%
Pyelonephritis
29%
Renin-Angiotensin System
28%
Pharmacogenetics
28%
Angiotensin Receptor Antagonists
28%
Chronic Renal Insufficiency
27%
Abdominal Aortic Aneurysm
27%
Ascites
24%
Urinary Tract Infections
23%
Renal Insufficiency
22%
Angiotensin I
22%
Gases
20%
Population
19%
Cause of Death
19%
Fibrosis
18%
Chronic Kidney Failure
18%
Angiotensin II
18%
Allografts
17%
Denmark
16%
Retrospective Studies
16%
Clinical Trials
16%
Mathematics
Angiotensin
93%
Congestive Heart Failure
84%
Inhibitor
62%
Enzymes
59%
Pharmacodynamics
36%
Angiotensin II
35%
Gene
34%
Cohort Study
32%
Stratification
27%
Agriculture & Biology
angiotensin-converting enzyme inhibitors
70%
heart failure
69%
pharmacogenomics
38%
cohort studies
34%
pharmacodynamics
32%
carboxylesterase
31%
angiotensin II
23%
angiotensin I
23%
death
19%